• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,235.31
  • 1.06 %
  • $86.04
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Clene Inc. (CLNN) Stock Price, News & Analysis

Clene Inc. (CLNN) Stock Price, News & Analysis

Currency in USD Disclaimer

$3.94

-$0.15

(-3.65%)

Day's range
$3.9
Day's range
$4.18
50-day range
$3.88
Day's range
$6.83
  • Country: US
  • ISIN: US1856341029
52 wk range
$3.82
Day's range
$12
  • CEO: Mr. Robert Etherington MBA
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -14.79
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (CLNN)
  • Company Clene Inc.
  • Price $3.94
  • Changes Percentage (-3.65%)
  • Change -$0.15
  • Day Low $3.90
  • Day High $4.18
  • Year High $12.00

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/12/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $10.00
  • High Stock Price Target $10.00
  • Low Stock Price Target $10.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.41
  • Trailing P/E Ratio -0.91
  • Forward P/E Ratio -0.91
  • P/E Growth -0.91
  • Net Income $-49,504,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Clene Inc. Frequently Asked Questions

  • What were the earnings of CLNN in the last quarter?

    In the last quarter Clene Inc. earnings were on Wednesday, November, 13th. The Clene Inc. maker reported -$1.22 EPS for the quarter, beating analysts' consensus estimates of -$1.34 by $0.12.

  • What is the Clene Inc. stock price today?

    Today's price of Clene Inc. is $3.94 — it has decreased by -3.65% in the past 24 hours. Watch Clene Inc. stock price performance more closely on the chart.

  • Does Clene Inc. release reports?

    Yes, you can track Clene Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Clene Inc. stock forecast?

    Watch the Clene Inc. chart and read a more detailed Clene Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Clene Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Clene Inc. stock ticker.

  • How to buy Clene Inc. stocks?

    Like other stocks, CLNN shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Clene Inc.'s EBITDA?

    Clene Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Clene Inc.’s financial statements.

  • What is the Clene Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -75.6941896024, which equates to approximately -7,569.42%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Clene Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Clene Inc.'s financials relevant news, and technical analysis. Clene Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Clene Inc. stock currently indicates a “sell” signal. For more insights, review Clene Inc.’s technical analysis.

  • A revenue figure for Clene Inc. for its last quarter?

    Clene Inc. published it's last quarterly revenues at $87,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.